Aloysius Romero Domingo, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystonic Disorders | 29 | 2023 | 335 | 6.260 |
Why?
|
| Genetic Diseases, X-Linked | 23 | 2022 | 375 | 4.470 |
Why?
|
| Dystonia | 5 | 2021 | 356 | 2.020 |
Why?
|
| Parkinsonian Disorders | 4 | 2020 | 285 | 0.920 |
Why?
|
| Transcription Factor TFIID | 5 | 2019 | 149 | 0.880 |
Why?
|
| TATA-Binding Protein Associated Factors | 5 | 2019 | 102 | 0.870 |
Why?
|
| Histone Acetyltransferases | 5 | 2019 | 334 | 0.790 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2021 | 1129 | 0.690 |
Why?
|
| Movement Disorders | 2 | 2020 | 458 | 0.650 |
Why?
|
| Myelin Sheath | 1 | 2021 | 647 | 0.590 |
Why?
|
| Basal Ganglia Diseases | 4 | 2019 | 145 | 0.520 |
Why?
|
| Parkinson Disease | 4 | 2018 | 2838 | 0.510 |
Why?
|
| Sequence Analysis | 1 | 2016 | 239 | 0.510 |
Why?
|
| Chromosomes, Human, X | 2 | 2015 | 316 | 0.450 |
Why?
|
| Agammaglobulinemia | 1 | 2014 | 172 | 0.430 |
Why?
|
| Mutation | 12 | 2021 | 29807 | 0.340 |
Why?
|
| Basal Ganglia | 4 | 2023 | 549 | 0.340 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2385 | 0.330 |
Why?
|
| Philippines | 4 | 2019 | 89 | 0.320 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9561 | 0.300 |
Why?
|
| Hearing Loss | 1 | 2014 | 775 | 0.290 |
Why?
|
| Nerve Degeneration | 3 | 2019 | 741 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 1067 | 0.250 |
Why?
|
| Genetic Variation | 1 | 2018 | 6517 | 0.210 |
Why?
|
| Calcinosis | 3 | 2016 | 1478 | 0.200 |
Why?
|
| Corpus Striatum | 2 | 2018 | 1228 | 0.190 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 2 | 2021 | 7 | 0.190 |
Why?
|
| Protein Kinases | 2 | 2018 | 1613 | 0.180 |
Why?
|
| Pedigree | 4 | 2016 | 4577 | 0.180 |
Why?
|
| Putamen | 2 | 2019 | 295 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17703 | 0.170 |
Why?
|
| Brain Diseases | 2 | 2021 | 1545 | 0.170 |
Why?
|
| Penetrance | 1 | 2021 | 388 | 0.170 |
Why?
|
| Molecular Chaperones | 2 | 2021 | 743 | 0.170 |
Why?
|
| DNA Repeat Expansion | 1 | 2019 | 69 | 0.160 |
Why?
|
| Disease Progression | 2 | 2017 | 13427 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2018 | 1876 | 0.160 |
Why?
|
| Globus Pallidus | 1 | 2019 | 249 | 0.150 |
Why?
|
| Ocular Motility Disorders | 1 | 2018 | 142 | 0.140 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 782 | 0.140 |
Why?
|
| Tubulin | 2 | 2018 | 699 | 0.140 |
Why?
|
| Striatonigral Degeneration | 1 | 2016 | 13 | 0.140 |
Why?
|
| Hemiplegia | 1 | 2016 | 137 | 0.130 |
Why?
|
| Evoked Potentials | 2 | 2018 | 1016 | 0.130 |
Why?
|
| Cerebellar Ataxia | 1 | 2016 | 149 | 0.120 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 375 | 0.120 |
Why?
|
| Substantia Nigra | 1 | 2017 | 349 | 0.120 |
Why?
|
| Humans | 40 | 2023 | 755533 | 0.120 |
Why?
|
| Genetic Loci | 2 | 2021 | 2610 | 0.120 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 341 | 0.120 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 250 | 0.110 |
Why?
|
| Torticollis | 1 | 2014 | 66 | 0.110 |
Why?
|
| Alleles | 2 | 2021 | 6890 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2014 | 102 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2013 | 256 | 0.100 |
Why?
|
| X Chromosome Inactivation | 1 | 2014 | 225 | 0.100 |
Why?
|
| Haplotypes | 2 | 2018 | 2758 | 0.100 |
Why?
|
| Turner Syndrome | 1 | 2013 | 130 | 0.100 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2715 | 0.100 |
Why?
|
| Family Health | 1 | 2016 | 1261 | 0.100 |
Why?
|
| Phenotype | 6 | 2022 | 16478 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 745 | 0.100 |
Why?
|
| Atrophy | 3 | 2023 | 1615 | 0.100 |
Why?
|
| Cerebellum | 1 | 2018 | 1494 | 0.090 |
Why?
|
| Data Collection | 1 | 2020 | 3306 | 0.090 |
Why?
|
| Neural Inhibition | 1 | 2015 | 588 | 0.090 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 808 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 1289 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1872 | 0.090 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 1990 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 1825 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1758 | 0.090 |
Why?
|
| Middle Aged | 19 | 2021 | 218055 | 0.080 |
Why?
|
| Genotype | 2 | 2021 | 12891 | 0.080 |
Why?
|
| Male | 24 | 2021 | 356577 | 0.080 |
Why?
|
| Adult | 20 | 2023 | 217986 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2193 | 0.080 |
Why?
|
| Motor Cortex | 1 | 2015 | 988 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 1721 | 0.070 |
Why?
|
| Age of Onset | 3 | 2021 | 3304 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2017 | 2998 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 4629 | 0.070 |
Why?
|
| Serbia | 2 | 2016 | 13 | 0.070 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2015 | 1451 | 0.060 |
Why?
|
| Genome, Human | 1 | 2018 | 4407 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 5731 | 0.060 |
Why?
|
| Germany | 2 | 2019 | 867 | 0.060 |
Why?
|
| Aged | 7 | 2021 | 167376 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2014 | 3521 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 4286 | 0.060 |
Why?
|
| Case-Control Studies | 5 | 2021 | 21907 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2017 | 5937 | 0.060 |
Why?
|
| Decision Making | 1 | 2017 | 3898 | 0.050 |
Why?
|
| Iron | 2 | 2023 | 1780 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3967 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 36042 | 0.050 |
Why?
|
| Genes, sis | 1 | 2021 | 3 | 0.050 |
Why?
|
| Reaction Time | 2 | 2018 | 2069 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2018 | 2261 | 0.050 |
Why?
|
| Sex Factors | 1 | 2014 | 10493 | 0.040 |
Why?
|
| Young Adult | 5 | 2021 | 58025 | 0.040 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2018 | 11 | 0.040 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2018 | 40 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 428 | 0.040 |
Why?
|
| Female | 14 | 2019 | 387920 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4114 | 0.040 |
Why?
|
| Electroencephalography | 3 | 2018 | 6067 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 114 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 394 | 0.040 |
Why?
|
| Antiparkinson Agents | 1 | 2018 | 182 | 0.040 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2018 | 224 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 162 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2018 | 250 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 289 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 80745 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15746 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2017 | 338 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 974 | 0.030 |
Why?
|
| Heterozygote | 1 | 2021 | 2788 | 0.030 |
Why?
|
| Brain Waves | 1 | 2018 | 388 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 167149 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2018 | 12753 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 1288 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1094 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1574 | 0.030 |
Why?
|
| Serine | 1 | 2016 | 829 | 0.030 |
Why?
|
| Brain Mapping | 2 | 2018 | 6533 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2015 | 910 | 0.020 |
Why?
|
| Electromyography | 1 | 2016 | 1378 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1427 | 0.020 |
Why?
|
| Brain | 4 | 2021 | 26737 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 877 | 0.020 |
Why?
|
| Transfection | 1 | 2018 | 5781 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2017 | 8953 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1346 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2018 | 6237 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1735 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3447 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5863 | 0.020 |
Why?
|
| Family | 1 | 2018 | 3181 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 12444 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7587 | 0.020 |
Why?
|
| Affect | 1 | 2014 | 1487 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10811 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3606 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4413 | 0.020 |
Why?
|
| Child | 3 | 2021 | 79427 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 87236 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 41119 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2777 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18939 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13434 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12491 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15682 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17611 | 0.010 |
Why?
|
| Neurons | 1 | 2018 | 9384 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14330 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39179 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 6884 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18027 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20404 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58549 | 0.000 |
Why?
|